BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10460790)

  • 1. 1998 International Meeting on the Arylamine N-Acetyltransferases: synopsis of the workshop on nomenclature, biochemistry, molecular biology, interspecies comparisons, and role in human disease risk.
    Ilett KF; Kadlubar FF; Minchin RF
    Drug Metab Dispos; 1999 Sep; 27(9):957-9. PubMed ID: 10460790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in N-acetyltransferase research: 7th international workshop on N-acetyltransferases (NAT): workshop report.
    Lichter J; Golka K; Sim E; Blömeke B
    Arch Toxicol; 2017 Jul; 91(7):2715-2718. PubMed ID: 28331975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomenclature for N-acetyltransferases.
    Vatsis KP; Weber WW; Bell DA; Dupret JM; Evans DA; Grant DM; Hein DW; Lin HJ; Meyer UA; Relling MV
    Pharmacogenetics; 1995 Feb; 5(1):1-17. PubMed ID: 7773298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics, biochemistry, toxicology, microbiology and cancer research in one go.
    Rodrigues-Lima F; Dairou J; Laurieri N; Busi F; Dupret JM
    Pharmacogenomics; 2011 Aug; 12(8):1091-3. PubMed ID: 21843062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of the arylamine N-acetyltransferases: a symposium in honor of Wendell W. Weber.
    Hein DW; McQueen CA; Grant DM; Goodfellow GH; Kadlubar FF; Weber WW
    Drug Metab Dispos; 2000 Dec; 28(12):1425-32. PubMed ID: 11095579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arylamine N-acetyltransferases in prokaryotic and eukaryotic genomes: a survey of public databases.
    Vagena E; Fakis G; Boukouvala S
    Curr Drug Metab; 2008 Sep; 9(7):628-60. PubMed ID: 18781915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on consensus arylamine N-acetyltransferase gene nomenclature.
    Hein DW; Grant DM; Sim E
    Pharmacogenetics; 2000 Jun; 10(4):291-2. PubMed ID: 10862519
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacogenetics of the arylamine N-acetyltransferases.
    Butcher NJ; Boukouvala S; Sim E; Minchin RF
    Pharmacogenomics J; 2002; 2(1):30-42. PubMed ID: 11990379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetics of the N-acetyltransferases.
    Grant DM
    Pharmacogenetics; 1993 Feb; 3(1):45-50. PubMed ID: 8097948
    [No Abstract]   [Full Text] [Related]  

  • 10. A nomenclature system for metabolic gene polymorphisms.
    Garte S; Crosti F
    IARC Sci Publ; 1999; (148):5-12. PubMed ID: 10493244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative genomic and phylogenetic investigation of the xenobiotic metabolizing arylamine N-acetyltransferase enzyme family.
    Glenn AE; Karagianni EP; Ulndreaj A; Boukouvala S
    FEBS Lett; 2010 Jul; 584(14):3158-64. PubMed ID: 20621844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arylamine N-acetyltransferases.
    Sim E; Westwood I; Fullam E
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):169-84. PubMed ID: 17428149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAT--from bugs to brains. An overview of the 2nd International Workshop on the arylamine N-acetyltransferases.
    Rodrigues-Lima F; Blömeke B; Sim E; Dupret JM
    Pharmacogenomics J; 2002; 2(3):152-5. PubMed ID: 12082586
    [No Abstract]   [Full Text] [Related]  

  • 14. Current trends in N-acetyltransferase research arising from the 2007 International NAT Workshop.
    Boukouvala S; Westwood IM; Butcher NJ; Fakis G
    Pharmacogenomics; 2008 Jun; 9(6):765-71. PubMed ID: 18518853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of the human arylamine N-acetyltransferases.
    Grant DM; Goodfellow GH; Sugamori K; Durette K
    Pharmacology; 2000 Sep; 61(3):204-11. PubMed ID: 10971207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and functional characterization of arylamine N-acetyltransferases in eubacteria: evidence for highly selective acetylation of 5-aminosalicylic acid.
    Deloménie C; Fouix S; Longuemaux S; Brahimi N; Bizet C; Picard B; Denamur E; Dupret JM
    J Bacteriol; 2001 Jun; 183(11):3417-27. PubMed ID: 11344150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylator genotype-dependent expression of arylamine N-acetyltransferase and N-hydroxyarylamine O-acetyltransferase in Syrian inbred hamster intestine and colon. Identity with the hepatic acetylation polymorphism.
    Ogolla F; Ferguson RJ; Kirlin WG; Trinidad A; Andrews AF; Mpezo M; Hein DW
    Drug Metab Dispos; 1990; 18(5):680-5. PubMed ID: 1981720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase.
    Trinidad A; Hein DW; Rustan TD; Ferguson RJ; Miller LS; Bucher KD; Kirlin WG; Ogolla F; Andrews AF
    Cancer Res; 1990 Dec; 50(24):7942-9. PubMed ID: 2253236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polymorphism of arylamine acetyltransferase and monooxygenase participating in metabolism of aromatic amines].
    Ratnikova LA; Nizhniĭ SV; Iaguzhinskiĭ LS
    Izv Akad Nauk SSSR Biol; 1985; (3):442-55. PubMed ID: 4019895
    [No Abstract]   [Full Text] [Related]  

  • 20. Arylamine N-acetyltransferases and drug response.
    Meisel P
    Pharmacogenomics; 2002 May; 3(3):349-66. PubMed ID: 12052143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.